Health Condition 1: K839- Disease of biliary tract, unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Intervention3: Nil: Nil
Intervention4: Nil: This is an observational study
Sponsors
Institute of liver and biliary sciences
Eligibility
Inclusion criteria
Inclusion criteria: Biliary tract carcinoma patients who underwent resection Patients undergoing cholecystectomy benign biliary disease Voluntary healthy liver donors with no gallbladder pathology Patients undergoing cholecystectomy for conditions with high risk of malignancy
Exclusion criteria
Exclusion criteria: Patients who have taken H.pylori eradication previously
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the prevalence of Helicobacter sp. in Biliary tract cancers and benign biliary diseasesTimepoint: Base line | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess correlation of Helicobacter infection with disease stage in Biliary tract cancersTimepoint: Baseline;To assess the correlation of Helicobacter infection with high risk conditions Choledochal cyst Gallbladder polyp Porcelain gallbladder Primary sclerosing cholangitis Metaplasia or dysplasia Stone size more than 2 cm Abnormal pancreaticobiliary junction Chronic liver disease patients with Hepatitis B & C Timepoint: Baseline | — |
Countries
India
Contacts
Public ContactDr Nihar Ranjan Mohapatra
Institute of liver and biliary sciences
Outcome results
None listed